Mitochondrial Dysfunction Emerges as Key Link Between Air Pollution and Heart Disease
UCLA Health researchers identified blood biomarkers—long-chain dicarboxylate acids and medium- to long-chain acyl-carnitines—that rise after air pollution exposure in both mice and humans. These markers indicate mitochondrial damage, which impairs fat breakdown and leads to cellular stress that may precede cardiovascular disease. The findings, published in Arteriosclerosis, Thrombosis, and Vascular Biology, offer a mechanistic explanation for pollution's heart risks.
The UCLA team compared blood samples from two distinct study groups: mice inhaling diesel exhaust for two weeks, and 26 healthy Los Angeles nonsmokers who spent ten weeks in Beijing during the summers of 2014 and 2015. In both groups, exposure triggered measurable rises in long-chain dicarboxylate acids and medium- to long-chain acyl-carnitines—compounds already linked to fatty acid oxidation deficits in clinical populations.
These metabolite elevations point to mitochondrial impairment as an early biological consequence of pollution exposure. Because such damage precedes overt disease, the markers may eventually help clinicians identify vulnerable individuals before cardiovascular, metabolic, or gastrointestinal conditions fully develop, offering a window for earlier intervention.
This research could reshape how clinicians assess pollution-related health risks. Currently, no reliable early indicators exist for who will develop cardiovascular or metabolic disease from air pollution exposure—problems often surface only after substantial damage. If these biomarkers prove clinically useful, routine blood tests might flag mitochondrial stress years before disease manifests, enabling earlier monitoring or preventive care. The findings may also influence public health discussions about pollution thresholds, though broader application depends on validation in larger, more diverse populations and translation into practical screening tools.